Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. - Wikidata - awgldk - TriplyDB

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

http://www.wikidata.org/entity/Q34620441

about

Common variants of the vitamin D binding protein gene and adverse health outcomes Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012 Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention Type 2 diabetes as a risk factor for cognitive impairment: current insights.Relationship between insulin resistance and plasma vitamin D in adults.Obesity and inflammation: the linking mechanism and the complications Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes.Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes.Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.Metabolic syndrome and inflammatory biomarkers in adults: a population-based survey in Western region of iran.Hypoglycemic effect of polysaccharides with different molecular weight of Pseudostellaria heterophylla.Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes.Glycated hemoglobin and associated risk factors in older adults.The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults Association between circulating ascorbic acid, α-tocopherol, 25-hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study.Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial Positive association between 25-hydroxyvitamin D and C-reactive protein is confounded by hormonal contraceptive use Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009.Vitamin D Status Is Negatively Correlated with Insulin Resistance in Chinese Type 2 Diabetes.Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women.Metal-based anti-diabetic drugs: advances and challenges.Physical disability in the elderly with diabetes: epidemiology and mechanisms.Prevalence of vitamin d insufficiency in qatar: a systematic review.Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms.Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation.Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation Anti-hyperglycemic effect of fermented ginseng in type 2 diabetes mellitus mouse model.Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.

P2860

Q24596671-A485BC12-9114-49F8-BC8E-6C351A2AFEC0 Q26741391-4730348F-E970-4DD3-8A8E-62B74137897C Q26744045-BA59D928-C945-4A43-B622-ED7CA96F9387 Q28357789-33022E2A-C76E-4183-9570-D1DE5C5C1301 Q28602468-0091BE05-7E17-47AE-A980-98FE554F133D Q33627932-A8EF3C96-A149-4215-8B20-CF948ACBE090 Q33857774-47782307-AC83-46F5-89FE-178058FD2F4B Q33890183-E75F6308-D7A0-4470-B489-55CBD87ED068 Q33897331-D2A7CC95-E586-437F-9D90-F022A2F798BE Q33901112-060CB0E1-041D-4C8C-8D0E-26C4EF464269 Q33960856-D14A3E13-5766-4D72-B5F5-63D2E153E634 Q34256560-752E897B-DD2F-4758-9B36-C128FC1E7C57 Q34605273-DC5B33D6-F5BD-4267-BB7B-9CE8F6AEAA92 Q34997805-DF32CBB2-E545-4860-A40B-D3A4C63C9D92 Q35019127-843A2451-8872-46EC-B5FA-3E659E28707F Q35054998-CFD62AD3-E75F-45BE-9212-D74691BC6E2D Q35287950-F6E9D0AE-ED74-497F-B328-6F0F1FBCBEEC Q35588992-E5EFA609-4266-48E8-A614-4EEC7F145761 Q35594507-61C75A70-9AE8-4B96-B932-A2270CDBAA52 Q35637841-20ED2330-394E-4BCB-ACD2-C478509BA1C6 Q35986459-3E3A5CE4-04D9-40DB-8DA6-01B87AA0077F Q36049533-266B5EEC-D542-455B-BA35-2E1A99AD413D Q36092395-47CA6A70-38F0-4804-B23C-8D797AAE1191 Q36307999-97114E33-3A15-4114-8BCE-CA78FBCA47F3 Q36448338-B7696855-14C0-4D6F-BFC3-EC9B180DC466 Q36524096-2E1CABBB-2769-4455-858B-C082FF969790 Q36842132-B5EDFD95-F60B-483B-966E-098DF00FF7E5 Q36929729-60F3B0AE-F040-4899-AD91-80A6B2FFEFAB Q37060645-1E7DB297-B181-4218-B9F4-6D92B38EB512 Q37298658-462DB7C9-FEE7-4605-A8FD-8588A68D6FBC Q37471838-4ED89636-8E0F-4A3E-9BAA-961B3664F811 Q37707072-60A5C952-DC4D-438B-8493-2A9343B84B72 Q37900507-05634084-D096-402F-B648-F9E09A0C7FFB Q38136567-5FF2A0FE-F11A-43D3-99D1-5F68EE0ECE34 Q38244532-002F32DF-E1CE-4D91-A387-0E37BB73A8F0 Q39123665-4A37BB87-86B4-4398-8449-39BC027AB87D Q41783780-142C2673-67AC-4628-ACBD-C4DDDFD6052D Q41996902-B1BC3776-6917-43C8-B310-7C9D72AECFEF Q45138032-2EB989B0-1377-4166-944A-C407ADE09AAA Q47098257-6E6E904E-046D-4FA7-9DDE-0A404B916D07

P2860

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

http://www.wikidata.org/entity/Q34620441

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@ast

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@en

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@nl

type

label

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@ast

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@en

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@nl

prefLabel

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@ast

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@en

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@nl

P1433

Q34620441-370BF60F-F46F-4A7F-BB9F-7B819C8B6B5F

P1476

Q34620441-909C10E6-CB97-47B5-8912-5BD679F9D3CE

P2093

Q34620441-0A767980-09F9-460F-85B0-A55D02A7A3DE

Q34620441-3F6A905C-FA49-4F6A-949D-C85304D68CE6

Q34620441-586105C8-41F7-4CE8-8A11-35DD9C895D27

Q34620441-780D8351-90DF-4CFE-B960-39CB4383F247

Q34620441-94ED8626-8614-4846-80A5-EEB0A22C772F

Q34620441-B0D991BE-660E-4DBB-A9E8-0A8336CA507C

P2860

Q34620441-00A74C69-305B-4312-89EF-952C967C0B85

Q34620441-022051BA-143E-41CE-B84B-4DD8E9C36385

Q34620441-02796BD8-51C7-4510-AE34-8E9B1FB7C6FD

Q34620441-030C9120-87C8-453D-8E4D-CE2CC8B95590

Q34620441-03D629C2-ED4E-46FF-A220-0D6140B54480

Q34620441-04125B59-4F43-4E5B-BDAE-6F88C6F79529

Q34620441-06A287AD-31C7-497F-A01A-43D66BC80A4D

Q34620441-09F2D457-1C5B-4AC8-993B-99DC4EC5952E

Q34620441-0B9D028E-5564-404F-B4C9-A419A39BD8A1

Q34620441-0CE7305E-4D54-4B46-BDF6-29810BD5436C

P304

Q34620441-331F4E5A-C412-4515-8DF1-A35973A43107

P31

Q34620441-C862205C-609E-4714-A3B9-C788F465A964

P356

Q34620441-9104A056-9CAA-4EE8-B4A4-A18930C2FE1B

P478

Q34620441-63BFDFD1-A55B-43D3-80BD-71736068A281

P50

Q34620441-9FC170C9-A599-4829-A31A-02425FE514B6

P577

Q34620441-F5EEBC49-9C76-485D-85B6-77C5B1CE9F51

P698

Q34620441-4AD41B8C-80D2-4B96-958A-85E5AE2E0605

P921

Q34620441-D86F72F0-7391-4386-9EF0-1773DD78146E

Q34620441-F2A2F5F8-02D1-4930-B3F9-D43B935ECAAA

P932

Q34620441-0CA0EC6D-0000-4AC0-877A-B754320BF192

P356

P1433

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

P1476

Type 2 diabetes mellitus and i ...... and nutritional intervention.

@en

P2093

Ahmed El-Sohemy

http://www.w3.org/2001/XMLSchema#string

Alaa Badawi

http://www.w3.org/2001/XMLSchema#string

Bibiana Garcia Bailo

http://www.w3.org/2001/XMLSchema#string

David Ec Cole

http://www.w3.org/2001/XMLSchema#string

Mohamed Karmali

http://www.w3.org/2001/XMLSchema#string

Pierre Haddad

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Oral Antidiabetic Agents

Inflammation and insulin resistance

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Inflammation, stress, and diabetes

TLR signaling pathways

Antioxidants prevent health-promoting effects of physical exercise in humans

Natural health products, modulation of immune function and prevention of chronic diseases.

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Inflammation and metabolic disorders

P304

173-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSOTT.S9089

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21437087

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3047967

http://www.w3.org/2001/XMLSchema#string